Go Pro

Oric Pharmaceuticals (ORIC) Institutional Ownership

Oric Pharmaceuticals logo
$10.73 0.00 (0.00%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$10.74 +0.01 (+0.07%)
As of 04:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Oric Pharmaceuticals (NASDAQ:ORIC)

Current
Institutional Ownership
Percentage
95.05%
Number of
Institutional Buyers
(last 12 months)
112
Total
Institutional Inflows
(last 12 months)
$308.11M
Number of
Institutional Sellers
(last 12 months)
39
Total
Institutional Outflows
(last 12 months)
$90.50M
Get ORIC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oric Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ORIC Institutional Buying and Selling by Quarter

Oric Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/12/2026Defilade Capital Management L.P.842,928$10.68M1.5%N/A0.814%
5/20/2026Vivo Capital LLC1,848,786$23.42M1.9%-12.7%1.786%
5/19/2026Bank of America Corp DE1,043,159$13.22M0.0%+105.5%1.008%
5/18/2026California State Teachers Retirement System48,369$613K0.0%+42.4%0.047%
5/18/2026Redmile Group LLC415,710$5.27M0.3%-7.2%0.402%
5/16/2026The Manufacturers Life Insurance Company 182,139$2.31M0.0%+41.6%0.176%
5/16/2026Quantinno Capital Management LP25,526$323K0.0%+9.3%0.025%
5/16/2026SummitTX Capital L.P.42,446$538K0.0%N/A0.041%
5/16/2026Orbimed Advisors LLC2,693,929$34.13M0.6%-26.0%2.602%
5/14/2026Siren L.L.C.2,998,192$37.99M1.1%+197.6%2.896%
5/7/2026Dimensional Fund Advisors LP1,471,290$18.64M0.0%+19.9%1.421%
5/5/2026Bank of New York Mellon Corp190,470$2.41M0.0%+1.4%0.184%
5/1/2026Candriam S.C.A.574,085$7.27M0.0%N/A0.572%
4/27/2026 Y Intercept Hong Kong Ltd111,992$1.42M0.0%-67.2%0.112%
4/16/2026SG Americas Securities LLC16,093$204K0.0%-60.8%0.016%
3/9/2026Corient Private Wealth LLC12,512$102K0.0%N/A0.012%
2/19/2026Invesco Ltd.109,742$898K0.0%+19.8%0.113%
2/19/2026Corient Private Wealth LLC12,512$102K0.0%N/A0.013%
2/18/2026XTX Topco Ltd110,565$904K0.0%N/A0.114%
2/18/2026VARCOV Co.32,036$262K0.1%N/A0.033%
2/18/2026Virtus Investment Advisers LLC28,361$232K0.1%+141.0%0.029%
2/18/2026Wellington Management Group LLP191,823$1.57M0.0%+27.4%0.197%
2/18/2026Sphera Funds Management LTD.1,004,378$8.22M1.6%+132.7%1.031%
2/18/2026Superstring Capital Management LP255,370$2.09M1.1%+185.8%0.262%
2/18/2026Oxford Asset Management LLP19,638$161K0.1%N/A0.020%
2/18/2026Millennium Management LLC97,432$797K0.0%-30.6%0.100%
2/18/2026Ishara Investments LP160,000$1.31M1.5%N/A0.164%
2/18/2026Engineers Gate Manager LP10,335$85K0.0%N/A0.011%
2/18/2026Balyasny Asset Management L.P.950,214$7.77M0.0%-37.5%0.976%
2/18/2026Boothbay Fund Management LLC218,610$1.79M0.0%+97.2%0.224%
2/17/2026Freestone Grove Partners LP24,207$198K0.0%N/A0.025%
2/17/2026Logos Global Management LP450,000$3.68M0.2%N/A0.462%
2/17/2026Schonfeld Strategic Advisors LLC14,349$117K0.0%N/A0.015%
2/17/2026AQR Capital Management LLC174,279$1.43M0.0%+1.4%0.179%
2/17/2026MPM Bioimpact LLC1,798,717$14.71M1.7%+4.0%1.847%
2/17/2026ArrowMark Colorado Holdings LLC1,063,769$8.70M0.2%-3.1%1.092%
2/17/2026Paradigm Biocapital Advisors LP2,401,217$19.64M0.5%N/A2.466%
2/17/2026Price T Rowe Associates Inc. MD3,295,122$26.96M0.0%+14.8%3.383%
2/17/2026Integral Health Asset Management LLC1,200,000$9.82M0.5%+33.3%1.232%
2/17/2026Adage Capital Partners GP L.L.C.549,000$4.49M0.0%+22.7%0.564%
Ex-CIA Insider: “Prepare for a Mid-Term Meltdown” (Ad)

Former CIA and Pentagon advisor Jim Rickards - who correctly called the 2008 recession, Trump's 2016 election, and the Covid crisis - is now warning investors to prepare for a historic mid-term meltdown. Rickards outlines three specific steps he says everyday investors should take before things turn ugly. Those who act early may avoid the losses that could wipe out millions of unprepared portfolios.tc pixel

Click here to learn the three steps Rickards says to take now
2/17/2026California State Teachers Retirement System33,959$278K0.0%+3.9%0.035%
2/17/2026Russell Investments Group Ltd.207,037$1.69M0.0%+4,062.4%0.213%
2/17/2026Atom Investors LP289,962$2.37M0.2%+103.3%0.298%
2/17/2026State of Wisconsin Investment Board124,345$1.02M0.0%+38.5%0.128%
2/17/2026ExodusPoint Capital Management LP108,835$890K0.0%N/A0.112%
2/17/2026Graham Capital Management L.P.81,576$667K0.0%N/A0.084%
2/17/2026Polar Capital Holdings Plc502,364$4.11M0.0%+7.2%0.516%
2/16/2026Squarepoint Ops LLC229,383$1.88M0.0%+646.4%0.236%
2/16/2026NEXTBio Capital Management LP615,720$5.04M3.0%N/A0.632%
2/16/2026First Turn Management LLC2,010,307$16.44M1.9%-6.9%2.064%
2/16/2026Entropy Technologies LP22,799$186K0.0%N/A0.023%
2/16/2026Barclays PLC718,535$5.88M0.0%+290.3%0.738%
2/13/2026The Manufacturers Life Insurance Company 128,649$1.04M0.0%+1.6%0.132%
2/13/2026Stifel Financial Corp13,490$110K0.0%N/A0.014%
2/13/2026Kalehua Capital Management LLC267,059$2.19M2.0%N/A0.274%
2/13/2026Quarry LP16,000$131K0.0%+2,106.9%0.016%
2/13/2026Vivo Capital LLC2,118,384$17.33M1.1%-32.2%2.175%
2/13/2026Rafferty Asset Management LLC177,179$1.45M0.0%+107.0%0.182%
2/13/2026Charles Schwab Investment Management Inc.621,086$5.08M0.0%+3.0%0.638%
2/13/2026State Street Corp4,258,397$34.83M0.0%+77.1%4.373%
2/13/2026Caitong International Asset Management Co. Ltd4,528$37K0.1%+184.4%0.005%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC50,782$415K0.0%+118.6%0.052%
2/13/2026Wells Fargo & Company MN82,532$675K0.0%+61.9%0.085%
2/13/2026Lord Abbett & CO. LLC564,253$4.62M0.0%N/A0.579%
2/12/2026Federation des caisses Desjardins du Quebec4,000$33K0.0%+100.0%0.004%
2/12/2026Jane Street Group LLC244,033$2.00M0.0%+222.5%0.251%
2/12/2026DRW Securities LLC19,194$157K0.0%N/A0.020%
2/12/2026Renaissance Technologies LLC572,724$4.69M0.0%+3,849.8%0.588%
2/12/2026Dimensional Fund Advisors LP1,227,230$10.04M0.0%+54.6%1.260%
2/12/2026New York State Common Retirement Fund18,429$151K0.0%-59.1%0.019%
2/12/2026Swiss National Bank86,200$705K0.0%+30.4%0.089%
2/12/2026Nuveen LLC144,403$1.18M0.0%+4.9%0.148%
2/11/2026Deutsche Bank AG44,937$368K0.0%+5.7%0.046%
2/11/2026Franklin Resources Inc.1,212,547$9.92M0.0%+2.6%1.245%
2/11/2026JPMorgan Chase & Co.414,786$3.39M0.0%-66.2%0.426%
2/10/2026TD Asset Management Inc169,830$1.39M0.0%+12.0%0.174%
2/10/2026Goldman Sachs Group Inc.1,939,285$15.86M0.0%+114.3%1.991%
2/10/2026AXQ Capital LP10,366$85K0.0%N/A0.011%
2/10/2026Intech Investment Management LLC26,606$218K0.0%+53.1%0.027%
2/9/2026Geode Capital Management LLC1,750,694$14.32M0.0%+7.4%1.798%
2/9/2026Royce & Associates LP1,507,301$12.33M0.1%+3.3%1.548%
2/9/2026Sectoral Asset Management Inc.22,480$184K0.1%-93.2%0.023%
2/9/2026Blue Owl Capital Holdings LP515,000$4.21M0.3%N/A0.529%
2/6/2026Nano Cap New Millennium Growth Fund L P15,000$123K0.1%N/A0.015%
2/6/2026ProShare Advisors LLC16,392$134K0.0%+22.5%0.017%
1/29/2026UBS Group AG734,858$6.01M0.0%+116.6%0.755%
1/29/2026China Universal Asset Management Co. Ltd.15,870$130K0.0%-41.3%0.016%
1/28/2026Arizona State Retirement System12,163$99K0.0%+21.0%0.012%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank16,546$135K0.0%N/A0.017%
1/26/2026Mirae Asset Global Investments Co. Ltd.4,732$39K0.0%+26.0%0.005%
Elon's new "super startup" (Ad)

Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified a new venture quietly incubating inside Tesla. It has nothing to do with EVs, AI, or robotics, yet it generated $12 billion in 2025 alone. Blackstone calls the broader opportunity a $23 trillion investment runway. Adam believes investors who position themselves before July 22 are early. He's also giving away a free ticker pick in his latest briefing.tc pixel

Watch Adam O'Dell's full briefing and get his free ticker now
1/21/2026Palumbo Wealth Management LLC27,322$223K0.1%-37.9%0.028%
1/16/2026 Tema Etfs LLC27,854$228K0.0%N/A0.029%
1/14/2026 Hennion & Walsh Asset Management Inc.170,072$1.39M0.0%+15.7%0.175%
1/9/2026SG Americas Securities LLC41,016$336K0.0%+127.6%0.042%
1/1/2026JPMorgan Chase & Co.1,228,528$14.74M0.0%-8.0%1.261%
11/17/2025CANADA LIFE ASSURANCE Co5,593$65K0.0%N/A0.006%
11/17/2025Woodline Partners LP246,534$2.96M0.0%+0.9%0.253%
11/17/2025Dark Forest Capital Management LP29,851$358K0.0%N/A0.031%
11/17/2025Susquehanna Fundamental Investments LLC25,518$306K0.0%-41.2%0.026%
11/17/2025Polar Capital Holdings Plc468,610$5.62M0.0%N/A0.481%


ORIC Institutional Ownership - Frequently Asked Questions

During the previous two years, 156 institutional investors and hedge funds held shares of Oric Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($55.80M), Alkeon Capital Management LLC ($45.72M), FMR LLC ($44.88M), Siren L.L.C. ($37.99M), State Street Corp ($34.83M), Orbimed Advisors LLC ($34.13M), and Price T Rowe Associates Inc. MD ($26.96M).Learn more on Oric Pharmaceuticals' institutional investors.

95.05% of Oric Pharmaceuticals' stock is owned by institutional investors. Learn more on ORIC's institutional investor holdings.

Of the 143 institutional investors that purchased Oric Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Orbimed Advisors LLC ($2.94M), Paradigm Biocapital Advisors LP ($2.40M), Siren L.L.C. ($1.99M), State Street Corp ($1.85M), Vivo Capital LLC ($1.85M), MPM Bioimpact LLC ($1.80M), and Boxer Capital Management LLC ($1.73M).

Institutional investors have bought a total of 30,585,206 shares in the last 24 months. This purchase volume represents approximately $308.11M in transactions.

Of the 39 institutional investors that sold Oric Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: EcoR1 Capital LLC ($1.80M), Vivo Capital LLC ($1.28M), Balyasny Asset Management L.P. ($1.06M), JPMorgan Chase & Co. ($1.03M), Orbimed Advisors LLC ($947.83K), Integral Health Asset Management LLC ($350K), and Frazier Life Sciences Management L.P. ($344.86K).

Institutional investors have sold a total of 8,837,298 shares in the last 24 months. This volume of shares sold represents approximately $90.50M in transactions.



This page (NASDAQ:ORIC) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners